Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway-Reference-Cited by-同舟云学术

Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway

Published:2019-04 Issue: Volume:56 Page:1-14
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Zhou Wei-Min,Wu Gao-Liang,Huang Ji,Li Jin-Gao,Hao Chao,He Qiu-Ming,Chen Xiao-Dan,Wang Gong-Xian,Tu Xin-Hua

Publisher

Elsevier BV

Subject

Cell Biology

Reference34 articles.

1. miR-216a-5p acts as an oncogene in renal cell carcinoma;Chen;Exp Ther Med.,2018

2. Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma;Chen;Oncol. Lett.,2018

3. Metastases to both Parotid Glands six and twelve years after Resection of Renal Cell Carcinoma;Franzen;Case Rep. Med.,2018

4. betaArrestin2 Mediates Renal Cell Carcinoma Tumor Growth;Masannat;Sci. Rep.,2018

5. Rhein inhibits malignant phenotypes of human renal cell carcinoma by impacting on MAPK/NF-kappaB signaling pathways;Ma;Onco Targets Ther.,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer;Molecular Medicine;2024-04-26

2. NCAPH serves as a prognostic factor and promotes the tumor progression in glioma through PI3K/AKT signaling pathway;Molecular and Cellular Biochemistry;2024-04-08

3. Pan-cancer analysis reveals PDK family as potential indicators related to prognosis and immune infiltration;Scientific Reports;2024-03-07

4. Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics;Clinical Proteomics;2023-11-08

5. The dysfunctional immune response in renal cell carcinoma correlates with changes in the metabolic landscape of ccRCC during disease progression;Cancer Immunology, Immunotherapy;2023-11-08